Growth Metrics

Cme (CME) Net Income towards Common Stockholders (2016 - 2026)

Cme has reported Net Income towards Common Stockholders over the past 18 years, most recently at $1.2 billion for Q1 2026.

  • Quarterly Net Income towards Common Stockholders rose 23.7% to $1.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.2 billion through Mar 2026, up 18.53% year-over-year, with the annual reading at $4.0 billion for FY2025, 15.5% up from the prior year.
  • Net Income towards Common Stockholders was $1.2 billion for Q1 2026 at Cme, roughly flat from $1.2 billion in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $1.2 billion in Q4 2025 and troughed at $630.0 million in Q4 2022.
  • The 5-year median for Net Income towards Common Stockholders is $863.7 million (2024), against an average of $853.7 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: fell 27.57% in 2022 and later surged 35.23% in 2025.
  • Tracing CME's Net Income towards Common Stockholders over 5 years: stood at $630.0 million in 2022, then grew by 27.67% to $804.3 million in 2023, then increased by 7.39% to $863.7 million in 2024, then surged by 35.23% to $1.2 billion in 2025, then changed by 0.0% to $1.2 billion in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at $1.2 billion, $1.2 billion, and $896.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.